Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Leukemia & Lymphoma
|
November 1, 1995
Specific antisense oligomer anti Bcr-abl junctions in chronic myeloid leukemia: a cell cycle analysis and CFU-GM study
F X Mahon, F Belloc, I Vianes, et al.
British Journal of Haematology
|
November 25, 1998
Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire
R Garand, J Goasguen, A Brizard, et al.
Leukemia
|
February 1, 1993
Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations
J L Huret, A Brizard, R Slater, et al.
Clinical and Experimental Immunology
|
January 1, 1997
IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases
P Doré, E Lelièvre, F Morel, et al.
Leukemia
|
February 13, 2002
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia
H A Drabkin, C Parsy, K Ferguson, et al.
Leukemia
|
August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting
M Varella-Garcia, C J Hogan, L F Odom, et al.
Macromolecular Bioscience
|
June 20, 2020
Imaging the In Vivo Degradation of Tissue Engineering Implants by Use of Supramolecular Radiopaque Biomaterials
Hanna Talacua, Serge H M Söntjens, Shraddha H Thakkar, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Leukemia & Lymphoma
|
November 1, 1995
Specific antisense oligomer anti Bcr-abl junctions in chronic myeloid leukemia: a cell cycle analysis and CFU-GM study
F X Mahon, F Belloc, I Vianes, et al.
British Journal of Haematology
|
November 25, 1998
Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire
R Garand, J Goasguen, A Brizard, et al.
Leukemia
|
February 1, 1993
Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations
J L Huret, A Brizard, R Slater, et al.
Clinical and Experimental Immunology
|
January 1, 1997
IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases
P Doré, E Lelièvre, F Morel, et al.
Leukemia
|
February 13, 2002
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia
H A Drabkin, C Parsy, K Ferguson, et al.
Leukemia
|
August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting
M Varella-Garcia, C J Hogan, L F Odom, et al.
Macromolecular Bioscience
|
June 20, 2020
Imaging the In Vivo Degradation of Tissue Engineering Implants by Use of Supramolecular Radiopaque Biomaterials
Hanna Talacua, Serge H M Söntjens, Shraddha H Thakkar, et al.
Page
of 9